Bull and Bear

Bull and Bear

Verdict: Watchlist — the business transformation is real, but the stock already prices flawless execution at peak operating leverage while cash conversion remains structurally unproven. The single most important tension is whether the 0.30x three-year cash-conversion ratio is a temporary scaling artifact or the early signal of a receivables write-off cycle. Bull wins on business quality and structural positioning; Bear wins on valuation and earnings integrity. The evidence that would tip the verdict to Lean Long is two consecutive quarters of CFO exceeding net income with debtor days declining below 110 — proving the P&L is producing real cash, not just accounting profit. Until that proof arrives, the risk-reward at 49–72x adjusted earnings does not compensate for the downside history of a company that lost money in 8 of 12 fiscal years.

Bull Case

Bull's target: ₹75 (32% upside from ₹56.8). Method: FY27E normalized EPS of ₹2.50 at 30x P/E — a discount to the 48x sector median, justified by superior ROCE and OMS annuity but haircut for cash-conversion risk. Timeline: 12–18 months through Q2 FY27 results (November 2026). Primary catalyst: Q4 FY26 results (May–June 2026) confirming 60% revenue growth guidance and WTG EBITDA margin stability above 16%. Disconfirming signal: book-to-bill falling below 1.0x for two consecutive quarters.

Bear Case

Bear's downside target: ₹35 (38% downside from ₹56.8). Method: P/S compression to 3.0x on trailing revenue (still 4.3x the 12-year median), cross-checked against 25x normalized P/E on ₹1,100 Cr adjusted PAT. Timeline: 12–18 months spanning two earnings cycles where DTA tailwind exhausts and receivables mature. Primary trigger: Q4 FY26 or Q1 FY27 earnings miss where headline PAT drops 40%+ as DTA recognition ends. Cover signal: two consecutive quarters of CFO exceeding net income with debtor days declining below 110.

The Real Debate

Verdict

Verdict: Watchlist. Bear carries more weight on the question that matters most — whether reported earnings are real. The adjusted P/E of 49–72x on a cyclical single-product WTG manufacturer with 0.30x three-year cash conversion is a valuation that demands proof the P&L produces cash, and that proof has not arrived. The earnings quality tension is decisive: if DTA exhaustion drops headline PAT by 40% in the next two quarters, the sell-side estimate reset will compress multiples regardless of order-book strength. Bull's structural arguments — OMS annuity, operating leverage, and the cleanest balance sheet in Suzlon's history — are genuine and differentiated, but they are already embedded in a 5.16x P/S that is 7.5x the 12-year median. The condition that changes this verdict is straightforward: two consecutive quarters where CFO exceeds net income and debtor days decline below 110, proving the cash-conversion deficit is a commissioning-timing artifact rather than structural revenue-recognition aggression. Until that evidence materializes, the business deserves a watchlist and the stock does not deserve capital.